Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

PhoreMost gets £11mm in Series A round

18 May 2018

Executive Summary

UK drug discovery start-up PhoreMost Ltd. raised £11mm ($15mm) in its Series A financing led by returning shareholders Jonathan Milner, Amadeus Capital Partners, Cambridge Enterprise, and Parkwalk Advisors, and first-time backer Morningside Ventures. A representative from Parkwalk and Morningside will join the board.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By